These 3 Stocks from BSE 500 Jumped Over 5% Today; Do You Own Any?

The benchmark index S&P BSE 500 opened today at 34,089.61 and made its day high at 34,094.51, and it is trading in green today, up by more than 0.30%.

From the same space, these are the top 3 companies that outperformed the benchmark index and were up by more than 5% today.

AstraZeneca Pharma India Ltd

Shares of AstraZeneca Pharma India Ltd have jumped today by more than 5% on BSE. The stock opened at Rs 6,182.95 and touched its day high today at Rs 6,580.00 after the surge. On Friday, the shares of AstraZeneca Pharma India Ltd closed at Rs 6,011.75 a piece. The stock has a 52-week high of Rs 7,208.00 whereas the 52-week low stood at Rs 3,210.00. Currently, the promoters holding is around 75.00% whereas the institutional and non-institutional holdings are 6.50% and 18.50%, respectively.

Rail Vikas Nigam Ltd

Another top player today is Rail Vikas Nigam Ltd. The shares of Rail Vikas Nigam Ltd were up by more than 5% on BSE today. The scrip opened today at Rs 377.75 a piece and touched its 52-week high today at Rs 399.70. The 52-week high stood at Rs 399.70 whereas the 52-week low stood at Rs 110.50. Presently, the promoters are holding about 72.84% whereas the institutional and non-institutional holdings are 8.50% and 18.66% respectively.

Glenmark Pharmaceuticals Ltd

One more top gainer today which shot up by more than 5% is Glenmark Pharmaceuticals Ltd. The scrip closed on Friday at Rs 1,035.40 and opened today at Rs 1,031.50 a piece. Shares touched their 52-week high at Rs 1,119.70 after the surge. The present 52-week high of the stock stood at Rs 1,119.70, whereas the 52-week low is Rs 587.00. Presently, the promoters are holding about 46.55% whereas the institutional and non-institutional holdings are 34.78% and 18.58%, respectively.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet, and is subject to changes. Please consult an expert before making related decisions.